AUSTIN, Texas--(BUSINESS WIRE)--Mystic Pharmaceuticals, Inc. announces today that it has been granted U.S. Patent No. 7,963,089, “Deep Draw Container Forming Method,” for a key manufacturing technology of its VersiDoser™ and VRx2™ drug and biologic delivery systems. Mystic’s delivery platforms provide preservative free unit dose packaging and devices for delivery of ophthalmic and intranasal drugs and biologics.
